from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1514c/-

LFCtreatmentdescriptionclass of inhibitor

-0.776

Amikacinug/mL Amikacintranslation

-0.862

Cap5-10ug/mL Capreomycintranslation

-1.092

Rox10-50 ug/mL Roxithromycintranslation

-0.973

SM2-5 ug/mL Streptomycintranslation

-1.182

Tet5-10 ug/mL Tetracyclinetranslation

0.658

Rif0.2-5ug/mL Rifampicintranscription

0.643

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.596

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.765

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.684

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.284

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.365

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.264

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-2.323

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.236

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.523

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.824

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.453

Nigericin50 uM Nigericinrespiration

0.594

TRC10-150 ug/mL Triclosanrespiration

1.862

TRZ10-25 ug/mL Thioridazinerespiration

-0.757

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.841

menadione6-10 ug/mL Menadionerespiration

-0.020

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.547

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.058

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.360

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.891

NRP_1Non-replicating persistence stage 1dosRassociated

-0.380

Amp0.2mg/mL AmpicillincellWall

0.881

Cephalexin20-100 ug/mL CephalexincellWall

-0.605

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.056

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.287

EMB10-20 ug/mL EthambutolcellWall

-1.696

Eta12-40 ug/mL EthionamidecellWall

-1.826

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.163

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.520

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.278

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.457

BZA0.12 mg/mL BenzamidearomaticAmides

0.192

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.429

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.670

H2O24 mM hydrogen peroxideDNAdamaging

0.096

Levo10 ug/mL LevofloxacinDNAdamaging

0.581

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.804

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.254

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.614

UVUV-irradiationDNAdamaging

1.195

ARP41-4 ug/mL Antitubercular compound ARP4?

0.213

Antimycin12.5-50 ug/mL Antimycin A?

-0.812

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.603

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.219

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.410

PA8240.2-2 ug/mL PA-824?

-0.242

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.345

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.823

Verapamil50 uM Verapamil?

-1.422

mercaptoethanol2 mM 2-Mercaptoethanol?

0.254

methoxatin10-20 ug/mL Methoxatin?